Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Findings from A. Ciszewski and co-authors provide new insights into immunization
July 23rd, 2008
According to a study from Warsaw, Poland, " To evaluate the effect of influenza vaccination on the coronary events in patients with confirmed coronary artery disease (CAD). Methods and results Randomized, double-blind, placebo controlled study." "We included 658 optimally treated CAD patients; 477 men, mean age 59.9 +/- 10.3 years. Three hundred and twenty-five patients received the influenza vaccine, and 333 patients placebo. Median follow-up was 298 (interquartile range 263-317) days. Primary endpoint was the cardiovascular death. Its estimated 12-month cumulative event rate was 0.63% in the vaccine vs. 0.76% in controls (HR 1.06 95% CI: 0.15-7.56, P = 0.95). There...
Source: Vaccine Weekly (2008-07-23)
|
